Inflammatory Polyarthritis in the Older Adult Tara Snelgrove BSc, MSc; Proton Rahman MD, MSc, FRCPC Disclosures Geriatrics and Aging. 2006;9 (8):544-550. 0 ...

Although noninflammatory arthritis, such as osteoarthritis (Figure 1), is the predominant etiology behind these MSK symptoms, inflammatory arthritis can also occur within this population. As ...

Rheumatoid arthritis is the most common etiology for inflammatory arthritis in the older population, with an estimated prevalence of 2%. An older individual with inflammatory polyarthritis usually ...

Paraneoplastic Syndrome Inflammatory musculoskeletal conditions may be the presenting feature in the aging population as part of a paraneoplastic picture. Rare reports of polymyalgia rheumatica ...

"Polymyalgia Rheumatica Pipeline Analysis"DelveInsight's,“Polymyalgia Rheumatica – Pipeline Insight, 2025,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in ...

Polymyalgia rheumatica has been discussed extensively in the European medical literature; the article by de Sèze and his co-workers 2 is a comprehensive recent review. But only a few North ...

News Cost Of Living PIP People with these conditions could get £187 a week from DWP More than a million people across the UK are claiming PIP for these conditions ...

News Cost Of Living Your Money DWP payments of up to £749 due for people with muscle or joint conditions You can get help with the extra costs of a long-term health condition or disability and ...

The Tumultuous Tale of Th17-and the IL23/IL17 immune axis In this episode, we look at the history of the discovery of TH17 and the recognition of the IL-23/17 immune axis.

Editorial Archive Cranial Arteritis and Polymyalgia Rheumatica Published June 22, 1967 N Engl J Med 1967;276: 1442 ...

Arthritis is inflammation of the joints. The symptoms of arthritis include stiffness and joint pain. There are many types of arthritis. The two most common types are osteoarthritis (OA), caused by ...

In 2025, polymyalgia rheumatica should have a broad therapeutic armamentarium analogous to other common inflammatory diseases. Polymyalgia rheumatica is common within major pharmaceutical markets, ...